brain-disorder-2019-keynote

4 / 7

allied
academies
July 01-02, 2019 | Paris, France
Brain Disorders and Therapeutics
6th International Conference on
Page 13
Notes:
Journal of Brain and Neurology | Volume: 03
Theodore A Henderson
Neuro-Laser Foundation, USA
The viral etiology of Chronic Fatigue Syndrome: Proof for low-grade
CNS viral infections
Chronic Fatigue Syndrome (CFS) is a medically
unexplained disorder which presents with severe
fatigue, flu-like symptoms, and neuropsychological
impairments, which can include mental “fogginess”,
decreased concentration, poor memory, low motivation,
diminished mood, and increased duration of sleep. The
Centers for Disease Control and Prevention estimate that
between 1 and 4 million patients exist in the United States
alone, although less than 20% have been so diagnosed.
Although CFS was initially thought to be a psychosomatic
illness, research has recently shifted to determining the
biological basis to the disorder. In recent years, numerous
studies have demonstrated a link between chronic viral
infections and CFS. Viruses such as Epstein-Barr Virus (EBV),
Cytomegalovirus (CMV), and several herpes viruses (e.g.,
Herpes 1, 6, 7 – HSV-1, HHV-6, HHV-7) cause or contribute
to the symptoms of a large percentage of patient with CFS.
These infections are generally not acute, but represent
intracellular reactivation of an old infection; hence, an
elevation of IgM antibodies is typically not seen with
reactivated infections of EBV, CMV, or HHV-6. Furthermore,
a recent study demonstrated conclusively that HHV-6
can invade and replicate within human brain cells based
on the finding of HHV-6 virus in Cerebellar Purkinje cells
of a large number of human brains. These data will be
reviewed and the treatment of CFS as a viral illness will be
outlined. Clinical data from over 150 patients with CFS will
be presented. The distribution of active viral infections,
treatment protocols, response rates, and stepped therapy
to more aggressive antiviral therapies will be described.
Speaker Biography
Theodore A Henderson is founder of Neuro-Luminance Brain Health
Centers, Inc. and director of The Synaptic Space. He has extensive
training and experience to the practice of Psychiatry and brain sciences.
He trained in Psychiatry at the prestigious Barnes/Jewish Hospitals at
Washington University/St. Louis and Child & Adolescent Psychiatry at
the University of Colorado. He also has training in Radiology, Nuclear
Medicine, and the genetics of psychiatry. He established his private
practice in Centennial Colorado in July of 2000. He has achieved an
advanced level of understanding of psychopharmacology, referred to
as Master Psychopharmacologist. He lectures regularly and has written
or published on unique treatment approaches to depression, chronic
fatigue, ADHD, and anxiety. He also has taught courses on neuroimaging.
He is a guest editor for a number of journals, including JAMA, Journal of
Neuropsychiatry, and the Journal of Nuclear Medicine.
e: